Cognition Therapeutics (CGTX) Prepaid Assets (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Prepaid Assets of $932000.0 for Q1 2026, down 43.86% year-over-year from $1.7 million in Q1 2025, and down 12.73% quarter-over-quarter from $1.1 million in Q4 2025.
Cognition Therapeutics (CGTX) Prepaid Assets (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Prepaid Assets for 7 consecutive years, with $932000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 43.86% year-over-year to $932000.0; the TTM figure through Mar 2026 stood at $932000.0 (down 43.86% YoY), while the FY2025 annual figure was $1.1 million, down 42.58% from the prior year.
- Prepaid Assets declined to $932000.0 in Q1 2026 per CGTX's latest filing, from $1.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.0 million in Q4 2023 and bottomed at $932000.0 in Q1 2026.
- Historically, Prepaid Assets has averaged $1.8 million across 5 years, with a median of $1.8 million in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 214.19% — and 2026, when it tumbled 43.86%.
- Cognition Therapeutics' Prepaid Assets stood at $2.4 million in 2022, then climbed by 25.11% to $3.0 million in 2023, then slumped by 38.39% to $1.9 million in 2024, then sank by 42.58% to $1.1 million in 2025, then dropped by 12.73% to $932000.0 in 2026.
- Business Quant data shows CGTX's Prepaid Assets at $932000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 586,000.00 |
| Mar 31, 2026 | 932,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 3.02 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 2.38 Mn |
| Dec 31, 2022 | 2.41 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 2.01 Mn |
| Sep 30, 2021 | 571,000.00 |